Are PARP Inhibitors Ready for Prime Time in Metastatic Prostate Cancer? Maybe Not. Gonzalez-Padilla DA, Subiela JD. Eur Urol 2023 May 25:S0302-2838(23)02824-5. doi: 10.1016/j.eururo.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gonzalez-Padilla DA, Subiela JD. Are PARP Inhibitors Ready for Prime Time in Metastatic Prostate Cancer? Maybe Not. Eur Urol 2023 May 25:S0302-2838(23)02824-5. doi: 10.1016/j.eururo.2023.
PMID: 37244815